Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample

被引:3
|
作者
Radestig, Maya Arvidsson [1 ,2 ]
Skoog, Ingmar [1 ,2 ,3 ]
Skillback, Tobias [1 ,2 ]
Zetterberg, Henrik [2 ,4 ,5 ,6 ,7 ]
Kern, Jurgen [1 ]
Zettergren, Anna [1 ,2 ]
Andreasson, Ulf [2 ,4 ]
Wetterberg, Hanna [1 ,2 ]
Kern, Silke [1 ,2 ,3 ]
Blennow, Kaj [2 ,4 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Neuropsychiat,Epidemiol Unit, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Psychiat Cognit & Old Age Psychiat, Gothenburg, Sweden
[4] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden
[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England
[6] UK Dementia Res Inst UCL, London WC1N 3BG, England
[7] Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China
基金
欧盟地平线“2020”; 美国国家卫生研究院; 欧洲研究理事会;
关键词
Alzheimer's disease; Cerebrospinal fluid; CSF; biomarkers; Neurolfilament light; NfL; Neurogranin; ALZHEIMERS-DISEASE; NEUROFILAMENT LIGHT; TAU; NEUROGRANIN; DEMENTIA; PROTEIN; BRAIN; A-BETA(1-42); ASSOCIATION; MARKER;
D O I
10.1186/s13195-023-01193-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNeurofilament light (NfL) and neurogranin (Ng) are promising candidate AD biomarkers, reflecting axonal and synaptic damage, respectively. Since there is a need to understand the synaptic and axonal damage in preclinical Alzheimer's disease (AD), we aimed to determine the cerebrospinal fluid (CSF) levels of NfL and Ng in cognitively unimpaired elderly from the Gothenburg H70 Birth Cohort Studies classified according to the amyloid/tau/neurodegeneration (A/T/N) system.MethodsThe sample consisted of 258 cognitively unimpaired older adults (age 70, 129 women and 129 men) from the Gothenburg Birth Cohort Studies. We compared CSF NfL and Ng concentrations in A/T/N groups using Student's T-test and ANCOVA.ResultsCSF NfL concentration was higher in the A-T-N+ group (p=0.001) and the A-T+N+ group (p=0.006) compared with A-T-N-. CSF Ng concentration was higher in the A-T-N+, A-T+N+, A+T-N+, and A+T+N+ groups (p<0.0001) compared with A-T-N-. We found no difference in NfL or Ng concentration in A+ compared with A- (disregarding T- and N- status), whereas those with N+ had higher concentrations of NfL and Ng compared with N- (p<0.0001) (disregarding A- and T- status).ConclusionsCSF NfL and Ng concentrations are increased in cognitively normal older adults with biomarker evidence of tau pathology and neurodegeneration.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease
    Moore, Elizabeth E.
    Gifford, Katherine A.
    Khan, Omair A.
    Liu, Dandan
    Pechman, Kimberly R.
    Acosta, Lealani Mae Y.
    Bell, Susan P.
    Turchan, Maxim
    Landman, Bennett A.
    Blennow, Kaj
    Zetterberg, Henrik
    Hohman, Timothy J.
    Jefferson, Angela L.
    ALZHEIMERS & DEMENTIA, 2020, 16 (06) : 883 - 895
  • [22] Levels and Determinants of Inflammatory Biomarkers in a Swiss Population-Based Sample (CoLaus Study)
    Marques-Vidal, Pedro
    Bochud, Murielle
    Bastardot, Francois
    Luescher, Thomas
    Ferrero, Francois
    Gaspoz, Jean-Michel
    Paccaud, Fred
    Urwyler, Adrian
    von Kaenel, Roland
    Hock, Christoph
    Waeber, Gerard
    Preisig, Martin
    Vollenweider, Peter
    PLOS ONE, 2011, 6 (06):
  • [23] Biomarkers in population-based studies
    Glei, Dana
    Weinstein, Maxine
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) : 1943 - 1944
  • [24] Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
    Aitana Sogorb-Esteve
    Johanna Nilsson
    Imogen J. Swift
    Carolin Heller
    Martina Bocchetta
    Lucy L. Russell
    Georgia Peakman
    Rhian S. Convery
    John C. van Swieten
    Harro Seelaar
    Barbara Borroni
    Daniela Galimberti
    Raquel Sanchez-Valle
    Robert Laforce
    Fermin Moreno
    Matthis Synofzik
    Caroline Graff
    Mario Masellis
    Maria Carmela Tartaglia
    James B. Rowe
    Rik Vandenberghe
    Elizabeth Finger
    Fabrizio Tagliavini
    Isabel Santana
    Chris R. Butler
    Simon Ducharme
    Alexander Gerhard
    Adrian Danek
    Johannes Levin
    Markus Otto
    Sandro Sorbi
    Isabelle Le Ber
    Florence Pasquier
    Johan Gobom
    Ann Brinkmalm
    Kaj Blennow
    Henrik Zetterberg
    Jonathan D. Rohrer
    Alzheimer's Research & Therapy, 14
  • [25] Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
    Sogorb-Esteve, Aitana
    Nilsson, Johanna
    Swift, Imogen J.
    Heller, Carolin
    Bocchetta, Martina
    Russell, Lucy L.
    Peakman, Georgia
    Convery, Rhian S.
    van Swieten, John C.
    Seelaar, Harro
    Borroni, Barbara
    Galimberti, Daniela
    Sanchez-Valle, Raquel
    Laforce, Robert, Jr.
    Moreno, Fermin
    Synofzik, Matthis
    Graff, Caroline
    Masellis, Mario
    Tartaglia, Maria Carmela
    Rowe, James B.
    Vandenberghe, Rik
    Finger, Elizabeth
    Tagliavini, Fabrizio
    Santana, Isabel
    Butler, Chris R.
    Ducharme, Simon
    Gerhard, Alexander
    Danek, Adrian
    Levin, Johannes
    Otto, Markus
    Sorbi, Sandro
    Le Ber, Isabelle
    Pasquier, Florence
    Gobom, Johan
    Brinkmalm, Ann
    Blennow, Kaj
    Zetterberg, Henrik
    Rohrer, Jonathan D.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [26] Biomarkers in MSA and PSP:: Cerebrospinal fluid concentrations of axonal markers and beta-Amyloid
    Suessmuth, S. D.
    Brettschneider, J.
    Petzold, A.
    Kassubek, J.
    Landwehrmeyer, B.
    Ludolph, A. C.
    Tumani, H.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (03) : XVII - XVIII
  • [27] Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
    Novakova, Lenka
    Axelsson, Markus
    Khademi, Mohsen
    Zetterberg, Henrik
    Blennow, Kaj
    Malmestrom, Clas
    Piehl, Fredrik
    Olsson, Tomas
    Lycke, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 62 - 71
  • [28] Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
    Kulczynska-Przybik, Agnieszka
    Dulewicz, Maciej
    Doroszkiewicz, Julia
    Borawska, Renata
    Litman-Zawadzka, Ala
    Arslan, Daria
    Kulakowska, Alina
    Kochanowicz, Jan
    Mroczko, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [29] Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration
    Rite, I.
    Argueelles, S.
    Venero, J. L.
    Garcia-Rodriguez, S.
    Ayala, A.
    Cano, J.
    Machado, A.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2007, 85 (16) : 3607 - 3618
  • [30] Expression of protein biomarkers in cerebrospinal fluid in frontotemporal lobar degeneration and other neurodegenerations
    Mouchova, Z.
    Rohan, Z.
    Smetakova, M.
    Matej, R.
    VIRCHOWS ARCHIV, 2015, 467 : S209 - S210